Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Journal of Clinical Medicine
|
October 14, 2023
Thyroid Autoimmunity and SARS-CoV-2 Infection
Poupak Fallahi, Giusy Elia, Francesca Ragusa, et al.
Frontiers in Endocrinology
|
April 26, 2024
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose
Silvia Martina Ferrari, Armando Patrizio, Valeria Mazzi, et al.
Oncology Reports
|
March 9, 2018
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
Silvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Oncology Reports
|
March 9, 2018
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
Silvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Endocrine
|
April 2, 2026
The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro
Silvia Martina Ferrari, Francesca Ragusa, Giusy Elia, et al.
Journal of Clinical Immunology
|
February 16, 2023
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity
Laura Gragnani, Marcella Visentini, Serena Lorini, et al.
Journal of Autoimmunity
|
July 16, 2022
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases
Clodoveo Ferri, Laura Gragnani, Vincenzo Raimondo, et al.
Journal of Autoimmunity
|
November 15, 2021
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups
Clodoveo Ferri, Francesco Ursini, Laura Gragnani, et al.
Journal of Translational Autoimmunity
|
October 19, 2023
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase
Clodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, et al.
Current Pharmaceutical Design
|
September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Journal of Clinical Medicine
|
October 14, 2023
Thyroid Autoimmunity and SARS-CoV-2 Infection
Poupak Fallahi, Giusy Elia, Francesca Ragusa, et al.
Frontiers in Endocrinology
|
April 26, 2024
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose
Silvia Martina Ferrari, Armando Patrizio, Valeria Mazzi, et al.
Oncology Reports
|
March 9, 2018
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
Silvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Oncology Reports
|
March 9, 2018
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
Silvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Endocrine
|
April 2, 2026
The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro
Silvia Martina Ferrari, Francesca Ragusa, Giusy Elia, et al.
Journal of Clinical Immunology
|
February 16, 2023
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity
Laura Gragnani, Marcella Visentini, Serena Lorini, et al.
Journal of Autoimmunity
|
July 16, 2022
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases
Clodoveo Ferri, Laura Gragnani, Vincenzo Raimondo, et al.
Journal of Autoimmunity
|
November 15, 2021
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups
Clodoveo Ferri, Francesco Ursini, Laura Gragnani, et al.
Journal of Translational Autoimmunity
|
October 19, 2023
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase
Clodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, et al.
Current Pharmaceutical Design
|
September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Page
of 8